Effective November 27, 2023, the Board of Nuvation Bio Inc. appointed Moses Makunje as the company?s Principal Accounting Officer and Principal Financial Officer. Mr. Makunje, 45 years old, has served as the company?s Vice President, Finance since January 2022, and as Senior Director, Finance since July 2020. Prior to joining the Company, Mr. Makunje held a position as Corporate Controller at Maze Therapeutics Inc. from March 2019 until July 2020, and a position as Corporate Controller at Adverum Biotechnologies Inc. from July 2017 until March 2019.

Mr. Makunje started his professional career at Ernst & Young, where he worked in audit for 7 years serving clients in life sciences. Overall, Mr. Makunje has over 16 years of experience in finance, accounting and tax, and he is a Certified Public Accountant.